Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical studies with mismatched double-stranded RNA

D R Strayer, W A Carter, I Brodsky

    Texas Reports on Biology and Medicine
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anthropometric and performance measures for high school basketball players.

    Journal of athletic training·2006
    Same author

    High dose cyclophosphamide for severe refractory myasthenia gravis.

    Journal of neurology, neurosurgery, and psychiatry·2004
    Same author

    High-dose cyclophosphamide for severe systemic lupus erythematosus.

    Lupus·2002
    Same author

    High-dose cyclophosphamide without stem-cell rescue for refractory CIDP.

    Neurology·2002
    Same author

    Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.

    Annals of internal medicine·2001
    Same author

    Inhibition of thymidylate synthase activity by antisense oligodeoxynucleotide and possible role in thymineless treatment.

    Molecular pharmacology·2001

    Mismatched dsRNA therapy shows promise, potentially outperforming conventional interferon treatments. This novel approach may generate diverse interferons and overcome cellular resistance, offering a new therapeutic avenue.

    Area of Science:

    • Immunology
    • Virology
    • Molecular Biology

    Background:

    • Conventional interferon therapy faces limitations in targeting specific cell types and overcoming resistance.
    • Mismatched dsRNA (double-stranded RNA) therapy is an emerging approach with potential clinical applications.

    Purpose of the Study:

    • To evaluate the efficacy of mismatched dsRNA therapy compared to conventional interferon therapy.
    • To explore the mechanisms by which mismatched dsRNA exerts its therapeutic effects.

    Main Methods:

    • Initial human trials involving mismatched dsRNA therapy.
    • Analysis of interferon species generation and intracellular mediator activation.
    • Assessment of acquired cellular resistance to interferon.

    Related Experiment Videos

    Main Results:

    • Mismatched dsRNA therapy demonstrates clinical promise in early human trials.
    • Potential for generating multiple interferon species, reducing the need for specific targeting.
    • Activation of intracellular mediators and ability to override acquired cellular resistance to interferon.

    Conclusions:

    • Mismatched dsRNA therapy may be more efficacious than conventional interferon therapy.
    • This approach offers a versatile and potentially more effective strategy for interferon-based treatments.